EGFR and lung carcinoma: A study evaluated EGFR mutation status in 99 brain metastases from 51 patients with lung cancer, resulting in an AUC, accuracy, sensitivity, and specificity of 0.73, 78.6%, 81.3%, and 76.9%, respectively (21).